Univercells

Univercells

Univercells

We believe making biologics available and affordable for all can only happen by changing the rules. And by bringing out the best of technology innovations.
Type
B2c
Founded
2013
Raised
$89.9M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
€50,000,000
Venture capital - 2020
Kohlberg Kravis Roberts
$18,800,000
Venture capital (Series B) - 2018
Global Health Investment Fund
Team Size
1–10
Employees
€50,000,000 Venture capital
Pulse 2.0

Univercells Raises Up To €50 Million From KKR Platform

$18,800,000 Venture capital (Series B)
PE HUB

Univercells rakes in $18.8 mln Series B

Data leaks Messaging
FinSMEs

Univercells Closes €16M Series B Equity Financing

Funding Science
FinSMEs

Univercells Receives €2.4M Grant

Apps & Services
PE HUB

| Univercells nets $3.56 mln Series A

Technology Funding
$12,000,000 Grant
Andrew Lloyd & Associates

Univercells Receives $12 Million Grant to Develop Breakthrough Vaccine Manufacturing Platform